Compliance and Technology for Track and Trace
Pharmaceutical Technology spoke with Tim Kearns, pharmaceutical and medical devices manager at Videojet.
Pharmaceutical Technology spoke with Tim Kearns, pharmaceutical and medical devices manager at Videojet, about the implementation of DSCSA 2015 and 2017 deadlines, marking and coding challenges, and the different forms of technology used to print codes for track and trace.
Recent Videos
Related Content
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Article
Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
